PM Portfolio Manager Reports

From Portfolio Manager reports

Security report / AME

AME Operating Console

AMETEK remains a high-quality industrial technology compounder, but the current read is no longer just steady execution. Q1 2026 orders, margins, cash conversion, and raised guidance support the premium frame, while the pending Indicor acquisition turns the next proof window toward leverage, integration, return quality, and adjusted-to-GAAP cash validation.

Metadata Knowledge Lane Fallback Chart
Ticker AME
Knowledge reviewed 2026-07-04
Links checked 2026-07-05
Chart source Local API
Module 01 / Price

Selected-Security Chart

API required

Loading AME daily chart from the local report API.

Loading AME chart...

Module 02 / Proof window

Current Company View

Indicor proof burden
Next read Q2 and Q3 must show order conversion, resilient margins, cash-backed earnings, and clean Indicor financing disclosure.
Measured base

Q1 2026 sales were $1.928B, adjusted operating margin was 26.8%, and operating cash flow was $451.5M.

Main proof issue

The $5.0B Indicor deal and $4.0B delayed-draw term loan shift the debate to leverage, integration, and return discipline.

Valuation context

The July 2, 2026 local close of $234.62 implies roughly 29x the $8.04 FY2026 adjusted EPS guidance midpoint.

Next evidence

Watch Q2 earnings, book-to-bill, backlog conversion, segment margin bridge, free cash flow, debt cost, and pro forma leverage.

Q1 sales $1.928B Up 11% year over year
Orders +23% Record orders and backlog
Adj. op margin 26.8% GAAP operating margin about 26.7%
Q1 CFO / capex $451.5M / $25.5M Cash conversion ahead of net income
Indicor $5.0B About $1.1B annual acquired sales
Local close $234.62 July 2, 2026 market snapshot
Exposure Map

Business Profile, Segments, And Exposure

AMETEK is a diversified industrial technology company with two operating groups and a larger pending acquisition test.

Business model

High-margin niche industrial technology

EIG sells analytical, test, and measurement instrumentation. EMG sells engineered components, MRO services, precision motion, thermal management, specialty metals, interconnects, and medical or aerospace products.

Disclosure map

Two segments, acquisition economics pending

EIG and EMG segment sales and operating income are disclosed. Indicor pro forma margins, purchase accounting, synergies, debt cost, and leverage are not yet reported.

EIG profit engine

$1.265B Q1 sales and $373.9M segment operating income.

EIG contributed about two-thirds of Q1 sales and nearly 69% of disclosed segment operating income before corporate expense.

More useful evidence

Order conversion, segment margin durability, organic growth, and cost pass-through commentary.

EMG leverage

$663.9M Q1 sales and $170.8M segment operating income.

EMG is smaller than EIG, but the Q1 release showed strong operating leverage and First Aviation adds aerospace and MRO exposure.

More useful evidence

Whether margin expansion repeats under tariff, freight, component, and integration pressure.

Indicor

Scale opportunity with a new financing burden.

The announced acquisition adds about $1.1B of annual sales, but the $5.0B price makes returns and leverage the central medium-term evidence.

More useful evidence

Close terms, debt draw, interest cost, pro forma leverage, margin, recurring revenue, and integration cost disclosures.

Industrial channels

Supportive, selective backdrop.

Order visibility, niche pricing power, and aerospace/MRO demand help, while restrictive rates, tariffs, freight, components, and shipping risk still matter.

More useful evidence

Official orders, supplier delivery data, import cost pressure, and aerospace or defense conversion.

Value Driver Board

Relative Value And Value Drivers

The multiple can stay quality-backed only if operating proof and acquisition proof arrive together.

Backlog conversion
Record Q1 orders and backlog

High-single-digit FY2026 sales guidance needs Q2 and Q3 conversion, not just order intake.

Next: book-to-bill, backlog, organic sales, and Q2 guide update.
Margin quality
26.8% adjusted operating margin

EIG mix and EMG leverage support the premium frame if cost and integration pressure stay contained.

Next: segment bridge, core margin, tariff and freight commentary.
Cash conversion
$451.5M Q1 operating cash flow

Cash generation is the main support for deleveraging, dividends, and acquisition funding.

Next: working capital, capex, free cash flow, and adjusted-to-GAAP reconciliation.
Indicor financing
$4.0B delayed-draw term loan package

The acquisition can add quality scale, but debt cost and integration results decide whether returns stay durable.

Next: close status, tranche draw, debt cost, leverage, synergies, and purchase accounting.
Guidance Tests

Guidance Path And What Changed

Q1 guidance was constructive, but the next update must bridge standalone strength to acquisition-financed execution.

Question
Can orders become revenue?

Confirm Q2 and Q3 orders, backlog conversion, and organic sales support high-single-digit FY2026 growth.

Warn if book-to-bill, backlog, or segment sales decelerate without a clean demand bridge.

Question
Do margins hold through cost pressure?

Confirm segment margins remain near Q1 levels with contained component, freight, tariff, and mix pressure.

Warn if adjusted margin stability depends on recurring add-backs or weak GAAP conversion.

Question
Does Indicor preserve quality?

Confirm close disclosures show manageable leverage, reasonable debt cost, clean integration costs, and margin-consistent acquired economics.

Warn if pro forma economics remain opaque after close or if debt cost reduces capital-allocation flexibility.

Operating Evidence

Operating Evidence And KPIs

These tiles are the operating evidence checks for the next source occurrence.

Sales growth
$1.928B

Q1 2026 sales rose 11%; the guide needs high-single-digit FY2026 sales growth to remain credible.

Orders and backlog
+23% orders

The Q1 release cited record orders and backlog, making conversion the highest-signal near-term KPI.

Operating margin
26.8%

Adjusted operating margin was close to GAAP operating margin, but acquisition adjustments need monitoring.

Cash conversion
$426.0M

Q1 operating cash flow less capex supports the deleveraging and acquisition-capacity case.

Capital Ledger

Financial Quality And Capital Allocation

Pre-Indicor quality is strong; post-close quality depends on leverage, integration costs, and cash conversion.

Financial quality

Cash-backed earnings

FY2025 operating cash flow of $1.802B exceeded net income of $1.480B. Q1 2026 operating cash flow of $451.5M exceeded net income of $399.4M, with low capex relative to sales.

Capital allocation

Acquisition-first while deleveraging

FY2025 included $933.2M of business purchases, $434.0M of repurchases, and $285.3M of dividends. Indicor is large enough to compete with buybacks until leverage normalizes.

Position Board

Competitive Position

The evidence supports a narrow edge, with the acquisition model now under a larger proof test.

What AMETEK has

Margin-supported niches

EIG and EMG segment economics support differentiated instrumentation and engineered-product positions.

Low capital intensity

Capex was modest relative to sales in FY2025 and Q1 2026, supporting cash deployment flexibility.

M&A operating model

Recurring acquisition deployment is part of the AMETEK model and supports growth when returns remain disciplined.

What is not proven

Indicor returns

Pro forma margin, leverage, debt cost, synergies, purchase accounting, and integration costs are not yet reported.

Peer valuation depth

The latest source pair does not include a full peer filing, call, or valuation comparison.

Management tone

Full last-four-quarter earnings-call transcripts were not retrieved, limiting Q&A and narrative-drift confidence.

Street View

Ownership, Flows, Valuation, And Street View

Use dated official links and local market data as context, not as live consensus evidence.

Official coverage

AMETEK lists 15 covering firms

Checked 2026-07-05: AMETEK's analyst coverage page listed firms including Baird, BofA, KeyBanc, Mizuho, Oppenheimer, RBC, TD Cowen, Truist, Vertical, and Wolfe.

Dashboard use: coverage breadth, not a rating or target source. AMETEK IR analyst coverage
Market tape

$234.62 close

Local data through July 2, 2026 showed AME up 5.0% over one month, 12.2% year to date, and 28.9% over one year.

Dashboard use: the market is already underwriting quality and clean execution. Fallback chart
Valuation frame

Roughly 29x FY2026 adjusted EPS midpoint

The valuation can be justified by durable margins and cash conversion, but it leaves less room for Indicor or adjusted-quality slippage.

Dashboard use: separate company quality from price tolerance. Metadata source trail
Ownership and flow

Low short-interest signal

Proxy evidence showed Vanguard at 11.0% and BlackRock at 7.5%; local short interest was about 1.5% of weighted shares on June 15, 2026.

Dashboard use: capital allocation and leverage matter more than short pressure. Knowledge lane
Scenario Board

Scenario Assessment And Sensitivities

Scenarios hinge on whether strong standalone execution and Indicor evidence arrive together.

Base

Backlog converts, margins stay premium, cash conversion remains strong, and Indicor closes with manageable financing and integration signals.

Upside

Orders broaden, cost pressure stays contained, aerospace and MRO support persists, and Indicor disclosures reduce the leverage and return burden.

Downside

Orders soften, cost pass-through fails, debt costs rise, or Indicor integration and adjusted-to-GAAP divergence compress the premium multiple.

Trigger Stack

Monitoring Triggers

These are business evidence checks. Chart overlays remain in the shared overlay rules, outside this page.

Q2 and Q3 orders

Backlog conversion versus guide

Confirm high-single-digit FY2026 sales growth with orders and backlog converting into reported revenue.

Warn if orders, book-to-bill, backlog, or segment sales weaken while guidance stays unsupported.

Segment margin

EIG and EMG durability

Confirm consolidated margin stays near the Q1 level with clean segment bridge disclosure.

Warn if components, freight, tariffs, mix, or integration costs erode margin without a temporary bridge.

Indicor close

Financing and pro forma economics

Confirm disclosed profitability, integration cost, debt cost, leverage, and deleveraging path fit AMETEK's cash profile.

Warn if leverage, debt cost, or opaque pro forma economics make acquisition returns hard to verify.

Adjusted quality

GAAP and cash validation

Confirm operating cash flow and GAAP earnings support adjusted EPS growth.

Warn if acquisition, amortization, restructuring, or integration add-backs expand or become recurring.

Risk Punch Cards

Risks, Invalidations, And Quality Flags

The central risk is not a weak standalone company. It is a mismatch between premium expectations and acquisition-financed evidence.

Indicor execution
Basis

The $5.0B purchase and $4.0B term loan are large relative to AMETEK's normal bolt-on rhythm.

Warning

Higher leverage, worse profitability, elevated debt cost, or integration costs that dilute returns.

Reduce concern

Close disclosures show margins, cash conversion, and deleveraging consistent with AMETEK's model.

Premium multiple
Basis

Local market data imply roughly 29x the FY2026 adjusted EPS guide midpoint.

Warning

Modest order, margin, or acquisition-quality misses can compress a quality multiple.

Reduce concern

Clean revenue, margin, cash, and Indicor evidence support the premium frame.

Cost and supply
Basis

Electronics, metals, freight, tariffs, components, and shipping stress can pressure delivery and margins.

Warning

Cost pressure broadens before pricing or productivity offsets arrive.

Reduce concern

Segment margins remain durable with clear cost pass-through evidence.

Adjusted quality
Basis

Adjusted EPS and adjusted operating income are central to guidance and incentive framing.

Warning

Adjusted results diverge from GAAP earnings and operating cash flow after acquisition costs rise.

Reduce concern

GAAP, adjusted, and cash measures continue to point in the same direction.

Source gaps
Basis

Transcripts, rating-agency reports, current consensus, full peer work, and local 13F coverage remain incomplete.

Warning

Management tone, peer valuation, or holder concentration moves faster than the filed source lane captures.

Reduce concern

Next source occurrence adds transcripts, rating context, peer comps, consensus, and ownership depth.

Diagnostics

Diagnostics, Freshness, And Known Unknowns

Freshness is explicit because this page is a projection of a filed source lane, not a research refresh.

Freshness

Stale local filing metadata, current source pair
Source run

Latest filed AME source pair generated July 4, 2026.

Market data

Local market snapshot runs through July 2, 2026 because July 4 was a U.S. holiday weekend.

Web check

AMETEK IR, Q1 release, filings, analyst coverage, and investor presentation links checked July 5, 2026.

Known unknowns

Proof items still missing
Indicor pro forma

Margins, synergies, purchase-accounting effects, integration costs, leverage, and returns are not yet reported.

Transcript coverage

Full last-four-quarter call transcripts were not retrieved, limiting narrative-history confidence.

Peer and holder depth

Full peer filing and valuation work plus local 13F holder coverage remain incomplete.

Categories